ESPERITE NV (ESP) AND PBKM (FAMICORD GROUP) SIGN EXCLUSIVE AGREEMENT REGARDING POTENTIAL ACQUISITION OF CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS.
Amsterdam, the Netherlands – 22 February 2019
read more
ESPERITE (ESP) : L1 Capital subscribes to the 18th tranche of investment today
Amsterdam, The Netherlands – 17 May 2018
read more
Continuation of support to Esperite’s strategy, commercial activities and development of innovative technologies in the field of genetics and regenerative medicines.
Amsterdam, The Netherlands – 11 April 2018
ESPERITE (ESP) : L1 Capital subscribes to the 16th tranche of investment today
Amsterdam, The Netherlands – 2 March 2018
Continuation of support to Esperite’s strategy, commercial activities and development of innovative technologies in the field of genetics and regenerative medicines.
Amsterdam, The Netherlands – 16 February 2018
Esperite with BGI sequencing technology will enable the global population easier access to the gold standard in clinical genetic testing.
Amsterdam, The Netherlands – 31 January 2018
ESPERITE (ESP) : L1 Capital subscribes to the 14th tranche of investment today
Amsterdam, The Netherlands – 31 January 2018
ESPERITE (ESP) : L1 Capital subscribes to the 13th tranche of investment today
Amsterdam, The Netherlands – 16 January 2018
ESPERITE (ESP) : L1 Capital subscribes to the 12th tranche of investment today
Amsterdam, The Netherlands – 10 January 2018
Further support of Esperite’s strategy, commercial activities and development of innovative technologies in the field of genetics and regenerative medicines
Amsterdam, The Netherlands – 22 December 2017
